Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint

BACKGROUND: Cardiac magnetic resonance (CMR) can quantify myocardial infarct (MI) size and myocardium at risk (MaR), enabling assessment of myocardial salvage index (MSI). We assessed how MSI impacts the number of patients needed to reach statistical power in relation to MI size alone and levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Engblom, Henrik, Heiberg, Einar, Erlinge, David, Jensen, Svend Eggert, Nordrehaug, Jan Erik, Dubois‐Randé, Jean‐Luc, Halvorsen, Sigrun, Hoffmann, Pavel, Koul, Sasha, Carlsson, Marcus, Atar, Dan, Arheden, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943247/
https://www.ncbi.nlm.nih.gov/pubmed/26961520
http://dx.doi.org/10.1161/JAHA.115.002708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943247/
https://www.ncbi.nlm.nih.gov/pubmed/26961520
http://dx.doi.org/10.1161/JAHA.115.002708

Ejemplares similares